首页 > 最新文献

Heart, Lung and Circulation最新文献

英文 中文
Non-Vitamin K Antagonist Oral Anticoagulant Use in Underrepresented Populations in Atrial Fibrillation: A Survey of Australian Pharmacist Practice 在代表性不足的心房颤动人群中使用非维生素 K 拮抗剂口服抗凝药:澳大利亚药剂师实践调查
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-01 DOI: 10.1016/j.hlc.2024.06.066
{"title":"Non-Vitamin K Antagonist Oral Anticoagulant Use in Underrepresented Populations in Atrial Fibrillation: A Survey of Australian Pharmacist Practice","authors":"","doi":"10.1016/j.hlc.2024.06.066","DOIUrl":"10.1016/j.hlc.2024.06.066","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624007248/pdfft?md5=ab151afc4c5c7428f449421f938d1c37&pid=1-s2.0-S1443950624007248-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Antifibrotic Effects of Eplerenone in Non-Obstructive Hypertrophic Cardiomyopathy: A Double Blinded, Placebo-Controlled Trial 依普利酮对非梗阻性肥厚型心肌病的抗纤维化作用:双盲安慰剂对照试验
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-01 DOI: 10.1016/j.hlc.2024.06.029
{"title":"The Antifibrotic Effects of Eplerenone in Non-Obstructive Hypertrophic Cardiomyopathy: A Double Blinded, Placebo-Controlled Trial","authors":"","doi":"10.1016/j.hlc.2024.06.029","DOIUrl":"10.1016/j.hlc.2024.06.029","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624006875/pdfft?md5=f0c526ff0f7ba23158c415c49b585966&pid=1-s2.0-S1443950624006875-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141959839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contents Page 目录页
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-01 DOI: 10.1016/S1443-9506(24)01761-X
{"title":"Contents Page","authors":"","doi":"10.1016/S1443-9506(24)01761-X","DOIUrl":"10.1016/S1443-9506(24)01761-X","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S144395062401761X/pdfft?md5=1d518bcbca754ae0514469f4b08ab588&pid=1-s2.0-S144395062401761X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine-Learning Based Risk Prediction of Outcomes in Patients Hospitalised With COVID-19 in Australia: The AUS-COVID Score 基于机器学习的澳大利亚 COVID-19 住院患者预后风险预测:AUS-COVID 评分
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-01 DOI: 10.1016/j.hlc.2024.06.027
{"title":"Machine-Learning Based Risk Prediction of Outcomes in Patients Hospitalised With COVID-19 in Australia: The AUS-COVID Score","authors":"","doi":"10.1016/j.hlc.2024.06.027","DOIUrl":"10.1016/j.hlc.2024.06.027","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624006851/pdfft?md5=3454ec8d34566daa9046a83cbe0dd851&pid=1-s2.0-S1443950624006851-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Pulmonary Hypertension on Mortality and Intensive Care Unit Admission in Patients With SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis 肺动脉高压对 SARS-CoV-2 感染者死亡率和入住重症监护室的影响:系统回顾与元分析》。
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-01 DOI: 10.1016/j.hlc.2024.01.036

Aim

Severe COVID-19 can cause acute respiratory distress syndrome, hypoxia, systemic complications, and increased mortality. Pulmonary hypertension (PH) is a major global health issue associated with worsening symptoms and increased mortality. This systematic review aimed to assess the influence of PH onset among COVID-19 patients on all-cause mortality and intensive care unit (ICU) admission.

Method

An unrestricted search of five databases up to June 2022 was undertaken. Pulmonary hypertension was assessed using transthoracic echocardiogram, computed tomography, or right heart catheterisation. After duplicate screening, data extraction, and risk of bias assessment, random effects meta-analyses of odds ratios (OR) and their 95% confidence intervals (CI) were performed for all-cause mortality and ICU admission.

Results

From the 26 studies that were included (3,373 patients, 76% males, median age 62.6 years), PH in COVID-19 patients was significantly associated with higher odds for all-cause mortality (26 studies; OR 3.89; 95% CI 2.85–5.31; p<0.001) and higher odds for ICU admission (six studies; OR 2.50; 95% CI 1.69–3.70; p<0.001). Meta-regression/subgroup analyses by patient demographics, comorbidities, or therapeutic regimens, and sensitivity analyses did not find any differences.

Conclusion

Evidence from observational studies indicates that PH in COVID-19 patients is associated with increased odds of mortality and ICU admission.

目的严重的 COVID-19 可导致急性呼吸窘迫综合征、缺氧、全身并发症并增加死亡率。肺动脉高压(PH)是一个重大的全球性健康问题,会导致症状恶化和死亡率上升。本系统综述旨在评估COVID-19患者肺动脉高压发病对全因死亡率和重症监护室(ICU)入院率的影响。通过经胸超声心动图、计算机断层扫描或右心导管检查对肺动脉高压进行评估。经过重复筛选、数据提取和偏倚风险评估后,对全因死亡率和入住重症监护室的几率比(OR)及其 95% 置信区间(CI)进行了随机效应荟萃分析。结果从纳入的 26 项研究(3373 名患者,76% 为男性,中位年龄 62.结果在纳入的 26 项研究中(3373 名患者,76% 为男性,中位年龄 62.6 岁),COVID-19 患者的 PH 与较高的全因死亡率几率(26 项研究;OR 3.89;95% CI 2.85-5.31;p<0.001)和较高的入住 ICU 几率(6 项研究;OR 2.50;95% CI 1.69-3.70;p<0.001)显著相关。结论观察性研究的证据表明,COVID-19 患者的 PH 与死亡率和入住 ICU 的几率增加有关。
{"title":"The Effect of Pulmonary Hypertension on Mortality and Intensive Care Unit Admission in Patients With SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis","authors":"","doi":"10.1016/j.hlc.2024.01.036","DOIUrl":"10.1016/j.hlc.2024.01.036","url":null,"abstract":"<div><h3>Aim</h3><p>Severe COVID-19 can cause acute respiratory distress syndrome, hypoxia, systemic complications, and increased mortality. Pulmonary hypertension (PH) is a major global health issue associated with worsening symptoms and increased mortality. This systematic review aimed to assess the influence of PH onset among COVID-19 patients on all-cause mortality and intensive care unit (ICU) admission.</p></div><div><h3>Method</h3><p>An unrestricted search of five databases up to June 2022 was undertaken. Pulmonary hypertension was assessed using transthoracic echocardiogram, computed tomography, or right heart catheterisation. After duplicate screening, data extraction, and risk of bias assessment, random effects meta-analyses of odds ratios (OR) and their 95% confidence intervals (CI) were performed for all-cause mortality and ICU admission.</p></div><div><h3>Results</h3><p>From the 26 studies that were included (3,373 patients, 76% males, median age 62.6 years), PH in COVID-19 patients was significantly associated with higher odds for all-cause mortality (26 studies; OR 3.89; 95% CI 2.85–5.31; p&lt;0.001) and higher odds for ICU admission (six studies; OR 2.50; 95% CI 1.69–3.70; p&lt;0.001). Meta-regression/subgroup analyses by patient demographics, comorbidities, or therapeutic regimens, and sensitivity analyses did not find any differences.</p></div><div><h3>Conclusion</h3><p>Evidence from observational studies indicates that PH in COVID-19 patients is associated with increased odds of mortality and ICU admission.</p></div>","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624000763/pdfft?md5=dafb30f773f66c215f054b31866b7898&pid=1-s2.0-S1443950624000763-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140794881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Implications of Socioeconomic Status on Major Adverse Cardiovascular, Cerebrovascular Events (MACCE), and All-Cause Mortality 社会经济地位对主要不良心血管、脑血管事件 (MACCE) 和全因死亡率的长期影响。
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-01 DOI: 10.1016/j.hlc.2024.02.022

Background

Socio-economic status (SES) has a large impact on health through a complex interplay of upstream, midstream and downstream factors. However, little is known about the predictive role of SES on long-term major adverse cardiovascular, cerebrovascular events, and mortality (MACCE).

Aim

To determine the long-term relationship between SES and MACCE for men and women. The secondary endpoint was to determine the relationship between SES and all-cause mortality.

Method

A total of 3,034 participants (1,494 women and 1,540 men) were assessed at baseline in the Geelong Osteoporosis Study, a large regional Australian population cohort study. Area-based SES was assessed, utilising the Index of Relative Socio-Economic Disadvantage (IRSD) and grouped into quintiles. The primary endpoint, MACCE, was defined as a composite of myocardial infarction, heart failure hospitalisation, malignant arrhythmias, stroke, and all-cause mortality. The secondary endpoint was all-cause mortality. Baseline data including age, sex, smoking status and alcohol use, and comorbidities were collected between 1993–1997 for women, and 2001–2006 for men, with follow-up over 30 and 22 years, respectively. Logistic regression was utilised to assess MACCE and all-cause mortality outcomes across the SES quintiles.

Results

Participants lost to follow-up or with incomplete data collection were excluded leaving 2,173 participants eligible for analysis. SES was associated with MACCE outcomes. Compared with Quintile I (lowest SES stratum), the odds of MACCE for each IRSD stratum were: Quintile II, odds ratio (OR) 0.85 (95% confidence interval [CI] 0.65–1.13); Quintile III, OR 0.69 (95% CI 0.51–0.91); Quintile IV, OR 0.66 (95% CI 0.50–0.88); and, Quintile V, OR 0.55 (95% CI 0.41–0.72). In the adjusted model, an inverse trend was noted, with reducing MACCE outcomes with an increasing SES status; IRSD Quintile II, OR 0.85 (95% CI 0.62–1.17); Quintile III, OR 0.70 (95% CI 0.50–0.97); Quintile IV, OR 0.73 (95% CI 0.52–1.02); and, Quintile V, OR 0.54 (95% CI 0.39–0.74). SES was inversely associated with all-cause mortality; IRSD Quintile II (OR 0.87, 95% CI 0.66–1.16) failed to achieve significance however IRSD Quintile III (OR 0.65, 95% CI 0.48–0.88), Quintile IV (OR 0.59, 95% CI 0.44–0.80) and Quintile V (OR 0.46, 95% CI 0.34–0.62) had a lower risk of mortality compared with Quintile I. In the adjusted model, an inversely proportional trend was noted between SES and all-cause mortality; IRSD Quintile II (OR 0.82, 95% CI 0.59–1.15), IRSD Quintile III (OR 0.63, 95% CI 0.49–0.95), Quintile IV (OR 0.59, 95% CI 0.45–0.90) and Quintile V (OR 0.44, 95% CI 0.31–0.61) had fewer mortality events compared with IRSD Quintile I.

Conclusions

Our research indicates that being part of a lower socio-economic stratum is linked to a higher likelihood of experiencing negative cardiovascular and c

背景:社会经济地位(SES)通过上游、中游和下游因素的复杂相互作用对健康产生巨大影响。然而,人们对社会经济地位对长期主要不良心血管、脑血管事件和死亡率(MACCE)的预测作用知之甚少。次要终点是确定 SES 与全因死亡率之间的关系:方法:在吉隆骨质疏松症研究(Geelong Osteoporosis Study)这一澳大利亚大型地区性人口队列研究中,共对 3034 名参与者(1494 名女性和 1540 名男性)进行了基线评估。利用相对社会经济劣势指数(IRSD)对地区社会经济状况进行了评估,并将其分为五等分。主要终点 MACCE 被定义为心肌梗死、心力衰竭住院、恶性心律失常、中风和全因死亡率的综合。次要终点为全因死亡率。基线数据包括年龄、性别、吸烟和酗酒情况以及合并症,女性的基线数据收集时间为 1993-1997 年,男性的基线数据收集时间为 2001-2006 年,随访时间分别为 30 年和 22 年。利用逻辑回归评估了不同社会经济地位五分位数的MACCE和全因死亡率结果:结果:排除了失去随访或数据收集不完整的参与者,有2173名参与者符合分析条件。SES 与 MACCE 结果相关。与五分位数 I(最低 SES 层)相比,每个 IRSD 层的 MACCE 发生几率分别为五分位数 II 的几率比 (OR) 为 0.85(95% 置信区间 [CI]:0.65-1.13);五分位数 III 的几率比为 0.69(95% 置信区间 [CI]:0.51-0.91);五分位数 IV 的几率比为 0.66(95% 置信区间 [CI]:0.50-0.88);五分位数 V 的几率比为 0.55(95% 置信区间 [CI]:0.41-0.72)。在调整模型中,随着社会经济地位的提高,MACCE结果呈反向趋势:IRSD五分位数II,OR值为0.85(95% CI 0.62-1.17);五分位数III,OR值为0.70(95% CI 0.50-0.97);五分位数IV,OR值为0.73(95% CI 0.52-1.02);五分位数V,OR值为0.54(95% CI 0.39-0.74)。社会经济地位与全因死亡率成反比;IRSD 五分位数 II(OR 0.87,95% CI 0.66-1.16)未达到显著性,但与五分位数 I 相比,IRSD 五分位数 III(OR 0.65,95% CI 0.48-0.88)、五分位数 IV(OR 0.59,95% CI 0.44-0.80)和五分位数 V(OR 0.46,95% CI 0.34-0.62)的死亡风险较低。在调整模型中,SES 与全因死亡率之间呈反比趋势;与 IRSD 五分位数 I 相比,IRSD 五分位数 II(OR 0.82,95% CI 0.59-1.15)、IRSD 五分位数 III(OR 0.63,95% CI 0.49-0.95)、五分位数 IV(OR 0.59,95% CI 0.45-0.90)和五分位数 V(OR 0.44,95% CI 0.31-0.61)的死亡事件较少:我们的研究表明,社会经济地位越低,发生心脑血管负面事件的可能性就越大,同时总死亡率的风险也越高。社会经济地位是心血管疾病和中风长期预后的重要风险分层标志,值得进一步研究。
{"title":"Long-Term Implications of Socioeconomic Status on Major Adverse Cardiovascular, Cerebrovascular Events (MACCE), and All-Cause Mortality","authors":"","doi":"10.1016/j.hlc.2024.02.022","DOIUrl":"10.1016/j.hlc.2024.02.022","url":null,"abstract":"<div><h3>Background</h3><p>Socio-economic status (SES) has a large impact on health through a complex interplay of upstream, midstream and downstream factors. However, little is known about the predictive role of SES on long-term major adverse cardiovascular, cerebrovascular events, and mortality (MACCE).</p></div><div><h3>Aim</h3><p>To determine the long-term relationship between SES and MACCE for men and women. The secondary endpoint was to determine the relationship between SES and all-cause mortality.</p></div><div><h3>Method</h3><p>A total of 3,034 participants (1,494 women and 1,540 men) were assessed at baseline in the Geelong Osteoporosis Study, a large regional Australian population cohort study. Area-based SES was assessed, utilising the Index of Relative Socio-Economic Disadvantage (IRSD) and grouped into quintiles. The primary endpoint, MACCE, was defined as a composite of myocardial infarction, heart failure hospitalisation, malignant arrhythmias, stroke, and all-cause mortality. The secondary endpoint was all-cause mortality. Baseline data including age, sex, smoking status and alcohol use, and comorbidities were collected between 1993–1997 for women, and 2001–2006 for men, with follow-up over 30 and 22 years, respectively. Logistic regression was utilised to assess MACCE and all-cause mortality outcomes across the SES quintiles.</p></div><div><h3>Results</h3><p>Participants lost to follow-up or with incomplete data collection were excluded leaving 2,173 participants eligible for analysis. SES was associated with MACCE outcomes. Compared with Quintile I (lowest SES stratum), the odds of MACCE for each IRSD stratum were: Quintile II, odds ratio (OR) 0.85 (95% confidence interval [CI] 0.65–1.13); Quintile III, OR 0.69 (95% CI 0.51–0.91); Quintile IV, OR 0.66 (95% CI 0.50–0.88); and, Quintile V, OR 0.55 (95% CI 0.41–0.72). In the adjusted model, an inverse trend was noted, with reducing MACCE outcomes with an increasing SES status; IRSD Quintile II, OR 0.85 (95% CI 0.62–1.17); Quintile III, OR 0.70 (95% CI 0.50–0.97); Quintile IV, OR 0.73 (95% CI 0.52–1.02); and, Quintile V, OR 0.54 (95% CI 0.39–0.74). SES was inversely associated with all-cause mortality; IRSD Quintile II (OR 0.87, 95% CI 0.66–1.16) failed to achieve significance however IRSD Quintile III (OR 0.65, 95% CI 0.48–0.88), Quintile IV (OR 0.59, 95% CI 0.44–0.80) and Quintile V (OR 0.46, 95% CI 0.34–0.62) had a lower risk of mortality compared with Quintile I. In the adjusted model, an inversely proportional trend was noted between SES and all-cause mortality; IRSD Quintile II (OR 0.82, 95% CI 0.59–1.15), IRSD Quintile III (OR 0.63, 95% CI 0.49–0.95), Quintile IV (OR 0.59, 95% CI 0.45–0.90) and Quintile V (OR 0.44, 95% CI 0.31–0.61) had fewer mortality events compared with IRSD Quintile I.</p></div><div><h3>Conclusions</h3><p>Our research indicates that being part of a lower socio-economic stratum is linked to a higher likelihood of experiencing negative cardiovascular and c","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S144395062400163X/pdfft?md5=c48e7208a92e219630dc3f2da7e27925&pid=1-s2.0-S144395062400163X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140891984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Association of Age and Left Atrial Dysfunction in Patients With Atrial Fibrillation 心房颤动患者的年龄与左心房功能障碍的关系
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-01 DOI: 10.1016/j.hlc.2024.06.012
{"title":"The Association of Age and Left Atrial Dysfunction in Patients With Atrial Fibrillation","authors":"","doi":"10.1016/j.hlc.2024.06.012","DOIUrl":"10.1016/j.hlc.2024.06.012","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S144395062400670X/pdfft?md5=23f879313d5875e4b0e9b980d2dae8b3&pid=1-s2.0-S144395062400670X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nox5 in Human Peripheral Blood Mononuclear Cells: A Potential Prognostic Biomarker in Coronary Artery Disease 人类外周血单核细胞中的 Nox5:冠状动脉疾病的潜在预后生物标志物
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-01 DOI: 10.1016/j.hlc.2024.06.028
{"title":"Nox5 in Human Peripheral Blood Mononuclear Cells: A Potential Prognostic Biomarker in Coronary Artery Disease","authors":"","doi":"10.1016/j.hlc.2024.06.028","DOIUrl":"10.1016/j.hlc.2024.06.028","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624006863/pdfft?md5=9896d3822f167be60158e2778d9310e3&pid=1-s2.0-S1443950624006863-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improved Diagnosis of COVID-19 Vaccine-Associated Myocarditis With Cardiac Scarring Identified by Cardiac Magnetic Resonance Imaging 通过心脏磁共振成像发现心脏瘢痕,提高 COVID-19 疫苗相关心肌炎的诊断率
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-01 DOI: 10.1016/j.hlc.2024.06.007
{"title":"Improved Diagnosis of COVID-19 Vaccine-Associated Myocarditis With Cardiac Scarring Identified by Cardiac Magnetic Resonance Imaging","authors":"","doi":"10.1016/j.hlc.2024.06.007","DOIUrl":"10.1016/j.hlc.2024.06.007","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624006656/pdfft?md5=ff606196f71540aba18edfef74ed1e03&pid=1-s2.0-S1443950624006656-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Financial Burden of Guideline Directed Medical Therapy (GDMT) for Patients With Heart Failure in Australia 澳大利亚心力衰竭患者接受指南指导医疗疗法(GDMT)的经济负担
IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-01 DOI: 10.1016/j.hlc.2024.06.069
{"title":"The Financial Burden of Guideline Directed Medical Therapy (GDMT) for Patients With Heart Failure in Australia","authors":"","doi":"10.1016/j.hlc.2024.06.069","DOIUrl":"10.1016/j.hlc.2024.06.069","url":null,"abstract":"","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1443950624007273/pdfft?md5=c2ddee7229f305da60f9f5c5ee08ef5c&pid=1-s2.0-S1443950624007273-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Heart, Lung and Circulation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1